Our Latest News

Stay tuned with Golden Helix Foundation

 

 

The Golden Helix Academy is part of the educational activities of the Golden Helix Foundation. The main aim of the Golden Helix Academy is to provide, in concert with established academic institutions, e-learning training in the field of Genomic and Precision Medicine including but not limited to Pharmacogenomics and Genomic Medicine, Public Health Genomics, Genome Informatics, Economics and Health Technology Assessment in Genomics, Nutrigenomics and Ethics in genomics (Genethics). 

The Golden Helix Academy in order to cover your needs and meet your high level learning expectations, offers three different types of training:

E-Learning courses

E-learning training modules are related to Genomic Medicine topics, such as Economic Evaluation in genomic medicine, introduction to Bioinformatics for clinical genome interpretation, pharmacogenomics in clinical care and drug discovery and Nutrigenomics. All courses run on the Academy’s e-Learning platform. The Golden Helix Academy e-Learning platform has built-in communication tools to promote interaction among participants and tutors and provide you with a flexible, motivating and productive experience. They are available every trimester and designed for healthcare professionals and biomedical scientists, who wish to enrich their knowledge on these emerging disciplines. 

On-site training courses

On-site training courses are provided on a regular basis at our sites, aiming to provide hands-on experience to those who already work in, and those who would like to enter the Genomic and Precision Medicine disciplines.

On-demand on-site training

The Golden Helix Academy offers the option of on-site training on demand, where experienced instructors provide training of academic or corporate staff on demand at your premises, namely your institution or company in your own country. On-demand on-site training courses are tailor-made to meet your needs and time schedule. The themes of the on-demand on-site training revolve around Pharmacogenomics, Cancer Genomics, Economics and Health Technology Assessment, and Genome Informatics. 

  

Modules on all offered types of training are provided in English, as well as in local languages, where applicable. All modules lead to academic certificates. 

For further information, please contact This email address is being protected from spambots. You need JavaScript enabled to view it.

 

The Golden Helix Foundation in order to transfer and communicate the knowledge from researchers and scientists in the wider scientific community organizes conferences around the world with the main themes revolving around the fields of genomics, pharmacogenomics and personalized medicine.

These conferences provide the opportunity to establish partnerships and collaborations among senior scientists, while junior delegates can also benefit by interacting with the speakers, which may create short and long-term training opportunities.

Since 2008, there are 32 Golden Ηelix Conferences that have been organized in various locations worldwide, which could be used as a paradigm of a well-orchestrated effort to enrich genomics education among healthcare professionals and to increase genomic literacy among patients and the general public, specifically addressing the needs of participants from developing countries.

For 2018, the Golden Helix Foundation plans to organize the following conferences:

 

Genomic Medicine implementation in low-resource settings

November 28-30, 2018, Cape Town, South Africa


 
The 4th Global Genomic Medicine Collaborative Conference will be organized in Cape Town, South Africa, November 28-30, 2018.

The conference will mainly include scientific sessions that focus on the Implementation of Genomic Medicine in Low Resourcesettings.

Leaders in Genomic Medicine across the globe will be attending this highly interactive conference to define collaborative projects and strategies that will serve the global community to use genomic advances to improve clinical care.

Representatives from the developed and the developing world will share challenges and strategies to overcome them.

In addition, we will be convening industry and leaders of large genomic consortia to engage in the dialog about the potential to influence health care delivery.

The 4th Global Genomic Medicine Collaborative Conference will be held in the PRESIDENT Hotel, Cape Town, South Africa.

The meeting will be organized by the Global Genomic Medicine Collaborativeand the University of Cape Townas the local host and the Golden Helix Foundation, as G2MC partner. It is the first to be organized in Africa, following the successful events in the United States in 2014, in Singapore in 2015 and in Athens in 2017.

Online registration for this event is now open.

Read more ...

The 21st Golden Helix Pharmacogenomics Day will be organized in Singapore, August 7, 2018.

Local and international speakers will lecture on the impact of pharmacogenomics in various medical specialties, also focusing on the bioinformatics solutions in pharmacogenomics. The scientific sessions include presentations on pharmacogenomics research, translation of pharmacogenomics data from laboratory to the clinic and regional updates on Pharmacogenomics and Precision Medicine.

The meeting will be held at the Breakthrough Theaterette (Level 4, Matrix Building, Biopolis, Singapore).

The event is open for biomedical scientists, hospital and general pharmacists, specialists, general practitioners, medical students, laboratory technicians, regulators, healthcare insurers and others interested in pharmacogenomics.

This international event will be co-organized from the Golden Helix Foundation and the Surveillance and Pharmacogenomics Initiative for Adverse Drug Reactions(SAPhIRE) Network. The Surveillance and Pharmacogenomics Initiative for Adverse Drug Reactions (SAPhIRE) program is funded by the Biomedical Research Council (BMRC) of A*STAR, Singapore to improve drug safety by developing an active surveillance network for adverse drug reaction (ADR) monitoring and discovery of genomic biomarkers that are predictive of specific ADRs.

Online registration is now open.

 

The 5th U-PGx Personalized Medicine Day will be organized in Liverpool, UK on September 21st, 2018.

The main presentation and discussion topics will include the areas of Pharmacogenomics and its application in Clinical Practice, ηealth economics of pharmacogenomics while few lectures will also focus on the 100,000 Genomes Project.

The meeting will be held at the Royal Liverpool Hospital postgraduate Medical Centre lecture theatre.

This international event is open for clinical pharmacologists, hospital pharmacists, general pharmacists, specialists, general practitioners, medical students, laboratory technicians, regulators, healthcare insurers and others interested in pharmacogenomics.

The event will be co-organized from the Golden Helix Foundationand theUniversity of Liverpool, both partners of the Ubiquitous Pharmacogenomics (U-PGx) project, funded by the European Commission (H2020-668353). 

Join us and find out how the Ubiquitous Pharmacogenomics (U-PGx) consortium can contribute to more efficacious, safer and cost-effective drug treatment modalities accessible to every European patient.

Online registration is now open. Please click here to register for the event.

 

 

The 4th U-PGx Personalized Medicine Day will be organized in Stockholm, Sweden at 18th of June 2018.

The main presentation and discussion topics will revolve around the areas of pharmacogenomics, precision and genomic medicine. The meeting will be held at the Karolinska Institutetin the STRIX Lecture Hall (address: von Eulers väg 4, Karolinska Institutet 171 65 Solna). It is one of the world’s foremost medical universities. Karolinska Institutet is the largest centre of medical academic research in Sweden offering a wide range of medical courses and programmes.

This international event is οpen to clinical pharmacologists, hospital pharmacists, general pharmacists, specialists, general practitioners, medical students, laboratory technicians, regulators, healthcare insurers and others interested in pharmacogenomics.

The meeting will be co-organized by the Golden Helix Foundation and the Karolinska Institutet, both partners of the Ubiquitous Pharmacogenomics(U-PGx) project, funded by the European Commission (H2020-668353). This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 668353.

Join us and find out how the ubiquitous pharmacogenomics project can make pharmacogenomics available to every patient. Registrations are Free of Charge.